Related Experiment Video
Updated: Sep 20, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
[Impella 5.5®: the latest innovation in the field of left ventricular assist systems]
Gianpiero Buttiglione1, Alessandra Francica2, Marina Comisso3
1Dipartimento di Cardiochirurgia Universitaria, IRCCS Policlinico San Donato, San Donato Milanese (MI).
Abstract:
The Impella 5.5® (Abiomed Inc., Danvers, MA, USA) is a temporary mechanical circulatory support device utilized for the management of cardiogenic shock. In this review, we outline the device's key features, paying particular attention to its indications and contraindications, the surgical technique for implantation, and potential complications. Additionally, we emphasize the potential benefits of using the Impella as a bridge to left ventricular assistance device implantation, a safe strategy to mitigate the risk of right heart failure.
More Related Videos
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Heart Failure VI: Adjunct Therapies
Heart Failure Drugs: Inotropic Agents
Heart Failure V: Medical Management
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...

